Improving the Identification of High Risk Precursor B Acute Lymphoblastic Leukemia Patients with Earlier Quantification of Minimal Residual Disease

The stratification of patients with acute lymphoblastic leukemia (ALL) into treatment risk groups based on quantification of minimal residual disease (MRD) after induction therapy is now well accepted but the relapse rate of about 20% in intermediate risk patients remains a challenge. The purpose of...

Descripción completa

Detalles Bibliográficos
Autores principales: Karsa, Mawar, Dalla Pozza, Luciano, Venn, Nicola C., Law, Tamara, Shi, Rachael, Giles, Jodie E., Bahar, Anita Y., Cross, Shamira, Catchpoole, Daniel, Haber, Michelle, Marshall, Glenn M., Norris, Murray D., Sutton, Rosemary
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2013
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3795712/
https://www.ncbi.nlm.nih.gov/pubmed/24146872
http://dx.doi.org/10.1371/journal.pone.0076455

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3795712/
https://www.ncbi.nlm.nih.gov/pubmed/24146872
http://dx.doi.org/10.1371/journal.pone.0076455

Ejemplares similares